Natco Pharma's net profit soared 83% YoY to Rs 676 crore in Q2 FY25, driven by strong sales growth. Revenue also increased significantly, with exports and domestic businesses performing well.
New Delhi, Nov 12 (PTI) Natco Pharma on Tuesday said its consolidated net profit jumped 83 per cent on-year to Rs 676 crore in the September 2024 quarter, aided by robust sales.
The drug maker reported a net profit of Rs 369 crore in the July-September period of last fiscal.
Revenue from operations rose to Rs 1,371 crore as compared with Rs 1,031 crore in the year-ago period, the company said in a regulatory filing.
"The company has shown continued strong growth during the second quarter driven by exports formulation business and stable domestic pharmaceutical business," it stated.
The company said its board has declared a second interim dividend of Rs 1.5 per equity share of Rs 2 each for financial year 2024-25.
Shares of the drug firm ended 0.19 per cent down at Rs 1,393.15 apiece on the BSE.
Home » Market News » Natco Pharma Q2 Profit Surges 83% to Rs 676 Cr
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback